To examine whether targeting STAT3 by LLL12 inhibits not only VEGF but also other critical angiogenic factors in osteosarcoma tumors, we examined the levels of 55 angiogenesis-associate proteins using a human angiogenesis array. Here, VEGFA is linked to osteosarcoma.